Defining drug resistance beyond rifampicin: use of Xpert® MTB/XDR assay in tuberculous meningitis
- Xpert MTB/XDR can serve as a useful tool to rapidly identify resistance to INH, FLQ, SLID and ETM, thus offering targeted therapy to the patients of TBM.
Authors
- C Kaur
- Himanshu Joshi (ORCID: https://orcid.org/0000-0001-6994-2993)
- Neeraj Singla (ORCID: https://orcid.org/0000-0002-7983-1637)
- Vijeta Patial
- Ashish Kumar Kakkar (ORCID: https://orcid.org/0000-0001-7768-7304)
- Megha Sharma (ORCID: https://orcid.org/0000-0002-6740-0493)
- Aman Sharma (ORCID: https://orcid.org/0000-0003-0813-1243)
- Manish Modi (ORCID: https://orcid.org/0000-0002-5494-3704)
- Manoj Goyal (ORCID: https://orcid.org/0000-0001-7375-4215)
- Kusum Sharma
- Navneet Sharma
- Ritu Shree (ORCID: https://orcid.org/0000-0002-2437-5507)
- Supriya Sharma
Institutions
- Post Graduate Institute of Medical Education and Research (IN)
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Indian Journal of Medical Microbiology
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1016/j.ijmmb.2025.100912
- Citations
- 1
- Primary Topic
- Infectious Diseases and Tuberculosis
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Cepheid
- Indian Council of Medical Research